On May 2, the government opened Opt-in bookings for the AstraZeneca Covid-19 vaccine for eligible individuals as well as those over the age of 18.
This is significantly more than Round 1 which offered 260,000 doses.
Meanwhile, he added that individuals in control trials for the Astra Zeneca vaccines had only reported fevers as side effects so far.